The Effect of Therapeutic Touch and Emotional Freedom Technique on Postpartum Mood and Fatigue in Postpartum Women

NCT ID: NCT06440109

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Therapeutic touch (TD) is a non-pharmacological/integrated treatment method used to balance the body by regulating the imbalanced energy field in the individual or resolving blockages in energy flow. Emotional freedom technique (EFT) is a psychophysiological intervention that combines elements of somatic stimulation using acupuncture points. This research will be conducted as a randomized controlled experimental study to determine the effect of TD and EFT intervention on postpartum mood and fatigue in postpartum women. This study is planned to be conducted between April 2024 and June 2025 with postpartum women who meet the inclusion criteria and who apply to the Obstetrics and Gynecology Clinic of Necmettin Erbakan University Faculty of Medicine Hospital. This research; It was planned to be carried out with three groups: TD intervention, EFT intervention and control group. The population of the research consists of women who gave birth vaginally and those who gave birth vaginally in the relevant hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatigue Emotion Regulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EFT intervention

The application will be carried out in line with EFT application protocols. In this regard, women's home visits will be completed with 6 meetings, once every week. Each EFT session will last 15 minutes

Group Type EXPERIMENTAL

Emotional freedom technique (EFT)

Intervention Type OTHER

İntervention groups will be followed for six months and one of the six EFT therapies will be applied, one session every week.

TD intervention

The application will be carried out in line with TD application protocols. In this regard, women's home visits will be completed with 6 meetings, once every week. Each TD session will last 15 minutes

Group Type EXPERIMENTAL

Therapeutic touch (TD)

Intervention Type OTHER

İntervention groups will be followed for six weeks and one of the six TD therapies will be applied, one session every week.

Control grup

No intervention will be made. Women in the intervention groups will be followed for 6 weeks and receive standard care. The final test will be administered at the end of the sixth week

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Emotional freedom technique (EFT)

İntervention groups will be followed for six months and one of the six EFT therapies will be applied, one session every week.

Intervention Type OTHER

Therapeutic touch (TD)

İntervention groups will be followed for six weeks and one of the six TD therapies will be applied, one session every week.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Having a vaginal birth at term
* Being primiparous
* Postpartum 3rd-5th. to be in the days
* Being able to speak and understand Turkish
* Being 18 years or older
* Having a single and viable fetus
* Volunteering to participate in research
* Not having experienced TD or EFT treatment before

Exclusion Criteria

* A psychiatric diagnosis has been made,
* Having a chronic systemic disease,
* The newborn's need for treatment
* Having postpartum complications in the mother or baby
* Those who have sensitivity or problems with touch,
* Wounds, infections, etc. in places that need to be touched. existence of situations,
* Women who have any disability that would prevent communication (deafness, hearing impairment, etc., use of languages other than Turkish) will be excluded from the research.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

KTO Karatay University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aslıhan Turan, PhD (c)

Role: PRINCIPAL_INVESTIGATOR

KTO Karatay University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

KTO Karatay University

Karatay, Konya, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A-TURAN-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.